Stay updated on RC48-ADC in HER2 Gynecological Malignancies Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2 Gynecological Malignancies Clinical Trial page.

Latest updates to the RC48-ADC in HER2 Gynecological Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history, and older notices/revisions (the funding notice and v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedA new revision (v3.4.1) was added and the previous revision (v3.4.0) was removed, including a notice about government funding and the NIH Clinical Center status.SummaryDifference0.9%

- Check28 days agoChange DetectedShow glossary option and color-coded highlights (green for additions, red for deletions) with the revised revision label (v3.4.0).SummaryDifference1%

- Check35 days agoChange DetectedA new revision entry v3.3.4 was added to the study history and an older entry v3.3.3 was removed. This change affects the revision log only and does not alter the study details presented on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedNew history entries show sponsor RemeGen Co., Ltd. and the latest recruitment status update. The update is dated 2023-12 and marked as Verified with Unknown status.SummaryDifference0.9%

- Check64 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to RC48-ADC in HER2 Gynecological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2 Gynecological Malignancies Clinical Trial page.